Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 6082729, 13 pages
http://dx.doi.org/10.1155/2016/6082729
Review Article

Application of Traditional Chinese Medical Herbs in Prevention and Treatment of Respiratory Syncytial Virus

1Jiangsu Key Laboratory of Pediatric Respiratory Disease, Nanjing University of Chinese Medicine, Nanjing 210023, China
2Institute of Pediatrics, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China
3Jiangsu Engineering Research Center for Efficient Delivery System of TCM, Nanjing University of Chinese Medicine, Nanjing 210023, China
4Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China

Received 6 January 2016; Accepted 26 May 2016

Academic Editor: Troy Carlo

Copyright © 2016 Li Li Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Chang, K. C. Wang, D. E. Shieh, F. F. Hsu, and L. C. Chiang, “Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines,” Journal of Ethnopharmacology, vol. 139, no. 1, pp. 305–310, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Nair, D. J. Nokes, B. D. Gessner et al., “Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis,” The Lancet, vol. 375, no. 9725, pp. 1545–1555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. P. F. Wright, R. B. Belshe, H. W. Kim, L. P. Van Voris, and R. M. Chanock, “Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children,” Infection and Immunity, vol. 37, no. 1, pp. 397–400, 1982. View at Google Scholar · View at Scopus
  4. H. W. Kim, J. G. Canchola, C. D. Brandt et al., “Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine,” American Journal of Epidemiology, vol. 89, no. 4, pp. 422–434, 1969. View at Google Scholar · View at Scopus
  5. R. B. Belshe, L. P. Van Voris, and M. A. Mufson, “Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial,” Journal of Infectious Diseases, vol. 145, no. 3, pp. 311–319, 1982. View at Publisher · View at Google Scholar · View at Scopus
  6. M. J. Polak, “Respiratory syncytial virus (RSV): overview, treatment, and prevention strategies,” Newborn and Infant Nursing Reviews, vol. 4, no. 1, pp. 15–23, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. S. Bawage, P. M. Tiwari, S. Pillai, V. Dennis, and S. R. Singh, “Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus,” Advances in Virology, vol. 2013, Article ID 595768, 26 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. K. A. Shadman and E. R. Wald, “A review of palivizumab and emerging therapies for respiratory syncytial virus,” Expert Opinion on Biological Therapy, vol. 11, no. 11, pp. 1455–1467, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Rudraraju, B. G. Jones, R. Sealy, S. L. Surman, and J. L. Hurwitz, “Respiratory syncytial virus: current progress in vaccine development,” Viruses, vol. 5, no. 2, pp. 577–594, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. M. Empey, R. S. Peebles Jr., and J. K. Kolls, “Pharmacologic advances in the treatment and prevention of respiratory syncytial virus,” Clinical Infectious Diseases, vol. 50, no. 9, pp. 1258–1267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. C. Welliver, “Pharmacotherapy of respiratory syncytial virus infection,” Current Opinion in Pharmacology, vol. 10, no. 3, pp. 289–293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. W. Sidwell and D. L. Barnard, “Respiratory syncytial virus infections: recent prospects for control,” Antiviral Research, vol. 71, no. 2-3, pp. 379–390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Chen and B. Yu, “Certain progress of clinical research on Chinese integrative medicine,” Chinese Medical Journal, vol. 112, no. 10, pp. 934–937, 1999. View at Google Scholar · View at Scopus
  14. N. Wiseman, “Traditional Chinese medicine: a brief outline,” Journal of Chemical Information and Computer Sciences, vol. 42, no. 3, pp. 445–455, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Li and T. Peng, “Traditional Chinese herbal medicine as a source of molecules with antiviral activity,” Antiviral Research, vol. 97, no. 1, pp. 1–9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Shen, “A new golden age of natural products drug discovery,” Cell, vol. 163, no. 6, pp. 1297–1300, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Lindell, S. B. Morris, M. P. White et al., “A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without TH2 associated Vaccine-Enhanced disease,” PLoS ONE, vol. 6, no. 7, Article ID e21823, pp. 1–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. S. Barbas, T. E. Downing, K. R. Balsara et al., “Chronic aspiration shifts the immune response from Th1 to Th2 in a murine model of asthma,” European Journal of Clinical Investigation, vol. 38, no. 8, pp. 596–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. D. C. Newcomb and R. S. Peebles Jr., “Th17-mediated inflammation in asthma,” Current Opinion in Immunology, vol. 25, no. 6, pp. 755–760, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. F. O. Martinez, L. Helming, R. Milde et al., “Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences,” Blood, vol. 121, no. 9, pp. e57–e69, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. L. Cyr, I. Angers, L. Guillot et al., “TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model,” Vaccine, vol. 27, no. 3, pp. 421–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. L. Cyr, T. Jones, I. Stoica-Popescu, D. Burt, and B. J. Ward, “C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine,” Vaccine, vol. 25, no. 16, pp. 3228–3232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Dey, T. Liu, R. P. Garofalo, and A. Casola, “TAK1 regulates NF-κB and AP-1 activation in airway epithelial cells following RSV infection,” Virology, vol. 418, no. 2, pp. 93–101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K.-C. Wang, J.-S. Chang, L.-C. Chiang, and C.-C. Lin, “Sheng-Ma-Ge-Gen-Tang (Shoma-kakkon-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract,” Journal of Ethnopharmacology, vol. 135, no. 2, pp. 538–544, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Bartee, M. R. Mohamed, and G. McFadden, “Tumor necrosis factor and interferon: cytokines in harmony,” Current Opinion in Microbiology, vol. 11, no. 4, pp. 378–383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. Ooi, H. Wang, C.-W. Luk, and V. E. Ooi, “Anticancer and antiviral activities of Youngia japonica (L.) DC (Asteraceae, Compositae),” Journal of Ethnopharmacology, vol. 94, no. 1, pp. 117–122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. X.-H. Xie, N. Zang, S.-M. Li et al., “Resveratrol inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells,” Inflammation, vol. 35, no. 4, pp. 1392–1401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Zang, X. Xie, Y. Deng et al., “Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice,” Journal of Virology, vol. 85, no. 24, pp. 13061–13068, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. J. S. Chang, K. C. Wang, C. F. Yeh, D. E. Shieh, and L. C. Chiang, “Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines,” Journal of Ethnopharmacology, vol. 145, no. 1, pp. 146–151, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. S. E. Lee, M. K. Y. Cho, H. S. U. Hwang et al., “Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses,” Journal of Interferon & Cytokine Research, vol. 34, no. 11, pp. 902–914, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. S. Lee, E.-J. Ko, H. S. Hwang et al., “Antiviral activity of ginseng extract against respiratory syncytial virus infection,” International Journal of Molecular Medicine, vol. 34, no. 1, pp. 183–190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. C. F. Yeh, K. C. Wang, L. C. Chiang, D. E. Shieh, M. H. Yen, and J. S. Chang, “Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines,” Journal of Ethnopharmacology, vol. 148, no. 2, pp. 466–473, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-P. Deng, Y.-Y. Liu, Z. Liu et al., “Antiviral activity of Folium Isatidis derived extracts in vitro and in vivo,” American Journal of Chinese Medicine, vol. 41, no. 4, pp. 957–969, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. M. X. Su, Y. L. Li, Y. H. Zhou, and R. Z. Chen, “Study on the the antiviral and antibacterial activities of the flowers of Flos Pueraria omeiensis (China),” Journal of Jinan University (Medicine Edition), vol. 27, no. 2, pp. 204–208, 2006. View at Google Scholar
  35. X. Li, H. Y. Li, Z. P. Xie, Z. H. Chen, and J. J. Zhang, “The anti-respiratory syncytial virus effect of an active compound RG2-1 from Radix Gentianae in vitro,” Chinese Journal of Disease Control & Prevention, vol. 11, no. 2, pp. 154–156, 2007. View at Google Scholar
  36. Z. H. Chen, H. Y. Li, Z. P. Xie, J. J. Zhang, X. Li, and J. X. Wang, “The anti-respiratory syncytial virus effect of an active compound RG3-1 from Radix Gentianae in vitro,” Journal of Harbin Medical University, vol. 41, no. 4, p. 344, 2007 (Chinese). View at Google Scholar
  37. S. S. Li, H. Y. Li, Y. A. Piao, D. L. Liu, W. J. Tian, and Y. M. Dong, “The anti-respiratory syncytial virus effect of an active compound (AP3) from a Traditional Chinese Herb-herba patriniae in vivo,” Chinese Journal of Epidemiology, vol. 25, no. 2, pp. 150–153, 2004. View at Google Scholar
  38. F. M. Zhang, L. Liu, X. Li et al., “The extraction, purification and identification of an active compound (AP4) from Herba patriniae with its effect against the respiratory syncytial virus in vitro (Chin),” Journal of Chinese Medicinal Materials, vol. 31, no. 12, pp. 1879–1881, 2008. View at Google Scholar
  39. R. G. Liang, W. B. Liu, Z. N. Tang, and Q. Xu, “Inhibition on respiratory syncytial virus in vitro by flavonoids extracted from the core of Litchi Chinensis,” Journal of Fourth Military Medical University, vol. 27, no. 20, pp. 1881–1883, 2006 (Chinese). View at Google Scholar
  40. X. Q. Wang, H. Y. Li, X. Y. Liu et al., “The anti-respiratory syncytial virus effect of active compound of Glycyrrhiza GD4 in vitro,” Chinese Herbal Medicine Magazine, vol. 29, no. 7, p. 692, 2006. View at Google Scholar
  41. X. Q. Wang, H. Y. Li, X. Y. Liu et al., “In vitro evaluation of Secoiridoid Glucosides from the fruits of Ligustrum lucidum as antiviral agents,” Chinese Herbal Medicine Magazine, vol. 29, no. 7, p. 692, 2006. View at Google Scholar
  42. Y. Wang, M. Chen, J. Zhang et al., “Flavone C-glycosides from the leaves of Lophatherum gracile and their in vitro antiviral activity,” Planta Medica, vol. 78, no. 1, pp. 46–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. Y.-L. Li, K.-M. Li, M.-X. Su, K.-T. Leung, Y.-W. Chen, and Y.-W. Zhang, “Studies on antiviral constituents in stems and leaves of Pithecellibium clypearia,” Zhongguo Zhong Yao Za Zhi, vol. 31, no. 5, pp. 397–400, 2006. View at Google Scholar · View at Scopus
  44. S.-C. Ma, J. Du, P. P.-H. But et al., “Antiviral Chinese medicinal herbs against respiratory syncytial virus,” Journal of Ethnopharmacology, vol. 79, no. 2, pp. 205–211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. L.-Y. Ma, S.-C. Ma, F. Wei et al., “Uncinoside A and B, two new antiviral chromone glycosides from Selaginella uncinata,” Chemical and Pharmaceutical Bulletin, vol. 51, no. 11, pp. 1264–1267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. W.-S. Ho, J.-Y. Xue, S. S. M. Sun, V. E. C. Ooi, and Y.-L. Li, “Antiviral activity of daphnoretin isolated from Wikstroemia indica,” Phytotherapy Research, vol. 24, no. 5, pp. 657–661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Huang, X. Zhang, Y. Wang et al., “Antiviral biflavonoids from Radix Wikstroemiae (Liaogewanggen),” Chinese Medicine, vol. 5, article 23, pp. 2–6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. L. S. M. Ooi, H. Wang, Z. He, and V. E. C. Ooi, “Antiviral activities of purified compounds from Youngia japonica (L.) DC (Asteraceae, Compositae),” Journal of Ethnopharmacology, vol. 106, no. 2, pp. 187–191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Li, L. S. M. Ooi, H. Wang, P. P. H. But, and V. E. C. Ooi, “Antiviral activities of medicinal herbs traditionally used in southern mainland China,” Phytotherapy Research, vol. 18, no. 9, pp. 718–722, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Wang, J. F. Wu, L. W. Kong et al., “BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice,” Journal of Ethnopharmacology, vol. 154, no. 1, pp. 131–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. C. L. Wu, Z. Q. Yang, W. Hou, C. X. Du, and F. Luo, “Experimental study on Shuang huang lian oral liquid against respiroviruses (Chin),” Journal of Mathernatical Medicine, vol. 18, no. 6, pp. 592–594, 2005. View at Google Scholar
  52. H. Y. Mo, K. F. Lai, Y. N. Jiang, J. P. Xie, Y. X. Tan, and N. S. Zhong, “Effect of Shuang huang lian on the release of chemokine in RSV-infected A549 airway epithelial cell,” Academic Journal of Guangzhou Medical College, vol. 33, no. 2, p. 16, 2005 (Chinese). View at Google Scholar
  53. X. J. Huang, W. Hou, Y. L. Zhao, F. Luo, and Z. Q. Yang, “An experimental study on anti-respiratory syncytial virus with Xia sang ju extract,” Chinese Journal of Modern Drug Application, vol. 1, no. 8, pp. 11–14, 2007 (Chinese). View at Google Scholar
  54. Z.-G. Chen, H. Luo, S.-C. Wang, J.-Y. Xu, and J.-X. Li, “Antiviral effects of Jinxin oral liquid against respiratory syncytial virus infection in the BALB/c mice model,” Journal of Ethnopharmacology, vol. 162, no. 2, pp. 287–295, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Yuan, X. Z. Ren, Y. Q. Sun et al., “Multi-centered, single-blind, random controlled clinical study on Qing fei oral liquid for 166 children cases with respiratory syncytial virus pneumonia (Chin),” Journal of Traditional Chinese Medicine, vol. 50, no. 3, pp. 221–223, 2009. View at Google Scholar
  56. B. Yuan, L. H. Zhou, L. Li, C. J. Zhao, and Q. Q. Wu, “Regulatory effects of Qing fei oral liquid on Interleukin-6 and Interleukin-8 secreted by human epithelial cells infected with respiratory syncytial virus (Chin),” Journal of Emergency in Traditional Chinese Medicine, vol. 20, no. 4, pp. 596–598, 2011. View at Google Scholar
  57. X. Z. Ren, S. C. Wang, J. Q. Li, K. Yao, and X. L. Wu, “Experimental studies on main effects of Qing fei oral liquid for infant viral pneumonia,” Chinese Journal of Basic Medicine in Traditional Chinese Medicine, vol. 8, no. 10, pp. 22–25, 2005 (Chinese). View at Google Scholar
  58. D. J. Newman, G. M. Cragg, and K. M. Snader, “Natural products as sources of new drugs over the period 1981–2002,” Journal of Natural Products, vol. 66, no. 7, pp. 1022–1037, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. M. S. Butler, “The role of natural product chemistry in drug discovery,” Journal of Natural Products, vol. 67, no. 12, pp. 2141–2153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. Collaboration Research Group for Qinghaosu, “Antimalaria studies on Qinghaosu,” Chinese Medical Journal, vol. 92, no. 12, pp. 811–816, 1979. View at Google Scholar · View at Scopus
  61. A. Dondorp, F. Nosten, K. Stepniewska, N. Day, and N. White, “Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial,” The Lancet, vol. 366, no. 9487, pp. 717–725, 2005. View at Publisher · View at Google Scholar
  62. G. Sun, R. Ouyang, S. Chen et al., “Treatment of acute promyelocytic leukemia with all-trans retinoic acid. A five-year experience,” Chinese Medical Journal, vol. 106, no. 10, pp. 743–748, 1993. View at Google Scholar · View at Scopus
  63. S.-J. Chen, G.-B. Zhou, X.-W. Zhang, J.-H. Mao, H. De Thé, and Z. Chen, “From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia,” Blood, vol. 117, no. 24, pp. 6425–6437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. G. Bae, J.-R. Yu, J. Lee, J. Chang, and E.-K. Seo, “Identification of Nyasol and structurally related compounds as the active principles from Anemarrhena asphodeloides against respiratory syncytial virus (RSV),” Chemistry and Biodiversity, vol. 4, no. 9, pp. 2231–2235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Y. Fung and Y. C. Linn, “Developing traditional Chinese medicine in the era of evidence-based medicine: current evidences and challenges,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 425037, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Kramer and D. Cohen, “Functional genomics to new drug targets,” Nature Reviews Drug Discovery, vol. 3, no. 11, pp. 965–972, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Li, C.-H. Yu, H.-Z. Ying, and J.-M. Yu, “Antiviral effects of modified Dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model,” Journal of Ethnopharmacology, vol. 147, no. 1, pp. 238–244, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. Q. Liu, L. Lu, M. Hua et al., “Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory viral infections in vitro and in vivo,” Journal of Ethnopharmacology, vol. 150, no. 2, pp. 521–528, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. J. S. Chang, K. C. Wang, D. E. Shieh, and L. C. Chiang, “Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract,” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1149–1155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. J. S. Chang, C. F. Yeh, K. C. Wang, D. E. Shieh, M. H. Yen, and L. C. Chiang, “Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract,” Journal of Ethnopharmacology, vol. 147, no. 2, pp. 481–487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. Z. Xu, “Modernization: one step at a time,” Nature, vol. 480, no. 7378, pp. S90–S92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. W.-H. Ma and X.-H. Sun, “Discussion of time and space differentiation of three-yin and three-yang in Shanghan Lun,” Journal of Chinese Integrative Medicine, vol. 3, no. 4, pp. 257–259, 2005. View at Publisher · View at Google Scholar · View at Scopus